Advancing antibody-drug conjugates in gynecological malignancies: myth or reality?

• Asıl Yazarlar: Marta Nerone (Yazar), Maria Del Grande (Yazar), Cristiana Sessa (Yazar), Ilaria Colombo (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Open Exploration Publishing Inc., 2022-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Antibody-drug conjugates (ADCs) represent a new class of therapeutic agents designed to target specific antigens on tumor cells, combining the specificity of monoclonal antibodies to the cytotoxicity of classic chemotherapy agents. These drugs have been extensively studied both in solid and hematolo...